Bagatell, C. J. et al: "Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men", Journal of Clinical Endocrinology and Metabolism, 1994 79:561-567
Bhasin, S et al: "The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men", New England Journal of Medicine, 1996 335:1-7
Birgner, Carolina: "Anabolic androgenic steroids and central monoaminergic systems: Supratherapeutic doses of nandrolone decanoate affect dopamine and serotonin", Uppsala Universitetet, 2008
Bonetti, Antonio et al.: "Side Effects of Anabolic Androgenic Steroids Abuse", International Journal of Sports Medicin, 2008; 29: 679-687 (Läs artikel om studien här)
Dickermann, R. D. et al: "Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids", Cardiology, 1995 86:172-173
DiMeo AN, Wood RI. "Self-administration of estrogen and dihydrotestosterone in male hamsters". Horm Behav. 2006, 49(4):519-26.
DiMeo AN, Wood RI. "ICV testosterone induces Fos in male Syrian hamster brain". Psychoneuroendocrinology. 2006. 31(2):237-49.
Ehrnborg, C. "Growth Hormone in Athletes". Göteborgs Universitet.
Elashoff, J. D et al: "Effects of anabolic-androgenic steroids on muscular strength", Annals of Internal Medicine, 1991 115:387-393
Fanton, L. et al: "Heart lesions associated with anabolic steroid abuse: Comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits", Experimantal and Toxicologic Pathology: the official journal of Gesellschaft fur Toxikologische Pathologie, 2008 Nov 20
Fineschi V. et al: "Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders", Int J Legal Med. 2007 Jan;121(1):48-53. Epub 2005 Nov 15.
Forbes, G. B: "The effect of anabolic steroids on lean body mass: the dose response curve", Metabolism: Clinical and Experimental, 1985 34:571-573
Forbes G. B et al: "Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped", JAMA: The Journal of the American Medical Association, 1992 267:397-399
Gerber, PA et al: "The dire consequences of doping", Lancet. 2008 Aug 23;372(9639):656.
Hall, R. C.: "Abuse of supraphysiologic doses of anabolic steroids", Southern Medical Journal, 2005, 98(5), 550-555
Kanayama, G. et al: "Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study", Drug and Alcohol Dependence 2003 Jul 20;71(1):77-86.
Nordström A. et al: "Higher muscle mass but lower gynoid fat mass in athletes using anabolic androgenic steroids", Journal of Strength and Conditioning Research vol. 26:1, 2012, 246-250
Olivardia, Roberto, Ph.D. et al: "Muscle Dysmorphia in Male Weightlifters: A Case-Control Study", The American Journal of Psychiatry, 157:1291-1296, August 2000
Rohman, L.: "The relationship between anabolic androgenic steroids and muscle dysmorphia: a review", Eating Disorders 2009 May-Jun;17(3):187-99
Thiblin, I. et al: "Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings". Cardiovasc Pathol. 2011 Nov 18.
Thiblin, I. et al: "Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids". Drug Alcohol Depend. 2006 Feb 28;81(3):241-9. Epub 2005 Aug 30.
Wingert, N. et al: "Acute hepatitis and personality change in a 31-year-old man taking prohormone supplement SUS500", Psychosomatics 2010 Jul;51(4):340-4